2024
Trends and regional differences for fertility preservation procedures in women with breast cancer
Turan V, Bedoschi G, Lee D, Barbosa C, de Oliveira R, Sacinti K, Sonmezer M, Lambertini M, Massarotti C, Schaub A, Wang E, Gayete-Lafuente S, Dunlop C, Anderson R, Bang H, Oktay K. Trends and regional differences for fertility preservation procedures in women with breast cancer. Clinical Breast Cancer 2024 PMID: 39428290, DOI: 10.1016/j.clbc.2024.09.011.Peer-Reviewed Original ResearchWomen of reproductive ageFertility preservationBreast cancerTissue cryopreservationYoung womenReproductive ageOvarian tissue cryopreservationFertility preservation methodsNormal ovarian functionOvarian stimulation cyclesFertility preservation proceduresFertility preservation practicesDiagnosed breast cancerOocyte cryopreservationOvarian stimulationTertiary centerMulticenter studyOvarian functionStimulated cyclesParticipating centersRegional time trendsBreastCancerPreservation proceduresChemotherapyUtility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers
Erden M, Gayete-Lafuente S, Vural N, Oktay K. Utility and Outcomes of Ovarian Tissue Cryopreservation and Transplantation for Gynecologic Cancers. Obstetrics And Gynecology 2024, 144: 481-492. PMID: 39173181, PMCID: PMC11499045, DOI: 10.1097/aog.0000000000005708.Peer-Reviewed Original ResearchCryopreserved ovarian tissue transplantationOvarian tissue cryopreservationOvarian tissue transplantationTissue cryopreservationAutologous transplantationGynecologic cancerTissue transplantationOutcome of autologous transplantationPreserving ovarian functionCochrane Library databasesOvarian endocrine functionPooled-effect estimatesSystematic reviewRisk-of-bias assessmentOvarian stimulationHematologic malignanciesLonger-term outcomesFertility preservationOvarian functionBreast cancerLibrary databasesTransplantationGraft longevityCancerEndocrine function
2022
Chapter 11 Preoperative Evaluation and Preparation for Ovarian Tissue Transplant Surgery
Oktay K, Turan V. Chapter 11 Preoperative Evaluation and Preparation for Ovarian Tissue Transplant Surgery. 2022, 109-115. DOI: 10.1016/b978-0-12-823344-3.00009-1.Peer-Reviewed Original ResearchPreoperative evaluationTransplantation surgeryFertility preservation methodsOvarian tissue cryopreservationOvarian autotransplantationOvarian stimulationHealthy babyTransplant surgeryPrepubertal girlsTissue cryopreservationSurgeryWomenPreparation of womenOnly optionAutotransplantationChemotherapyBabiesEvaluationChapter 18 Approach to Ovarian Stimulation and In Vitro Fertilization in Patients With Transplanted Ovarian Tissue
Oktay K, Babayev S. Chapter 18 Approach to Ovarian Stimulation and In Vitro Fertilization in Patients With Transplanted Ovarian Tissue. 2022, 185-192. DOI: 10.1016/b978-0-12-823344-3.00010-8.Peer-Reviewed Original ResearchOvarian stimulationOvarian autotransplantsIVF outcomesOvarian tissueOptimal ovarian stimulationOvarian stimulation cyclesStandard ovarian stimulationTransplanted ovarian tissueFollicular growth patternOvarian transplantsExtrapelvic locationsStimulation cyclesVitro FertilizationSame womenStimulationWomenAutotransplantsSignificant differencesFertilization protocolsOutcomesTissueGrowth patternPatientsTransplantAvailable data
2019
Ovarian Stimulation in Women with Breast Cancer
Turan V, Oktay K. Ovarian Stimulation in Women with Breast Cancer. 2019, 105-115. DOI: 10.1007/978-3-030-24086-8_10.Peer-Reviewed Original ResearchFertility preservation optionsOvarian stimulationBreast cancerPreservation optionsEffective fertility preservation optionsEstrogen-sensitive malignanciesReproductive-aged womenCommon cancer typesCytotoxic chemotherapyGonadal failureAged womenOocyte cryopreservationNumber of womenCancer typesCancerWomenStimulationTreatmentHigh levelsChemotherapyPatientsMalignancyOptionsRadiotherapyEstradiol
2018
Ovarian tissue cryopreservation and transplantation
Bedoschi G, Oktay K. Ovarian tissue cryopreservation and transplantation. 2018, 148-152. DOI: 10.1201/9781351141680-19.Peer-Reviewed Original ResearchOvarian tissue cryopreservationOvarian cortical piecesFertility preservationAdvanced treatment strategiesOvarian transplantationCortical piecesOvarian stimulationSurvival outcomesOvarian functionTreatment strategiesTissue cryopreservationAccelerated phaseEarly detectionHeterotopic ovarian transplantationFertility preservation proceduresLower abdominal wallFirst descriptionOvarian endocrineInitial ischemiaOvarian cryopreservationPharmacological supportTransplant proceduresFollicle lossCancer careCancer patientsOvarian Stimulation and the Long-Term Risk of Cancer
Taylan E, Oktay K. Ovarian Stimulation and the Long-Term Risk of Cancer. 2018, 344-348. DOI: 10.1016/b978-0-12-801238-3.64898-5.Peer-Reviewed Original Research
2016
Embryo Cryopreservation in Breast Cancer Patients
Bedoschi G, Oktay K. Embryo Cryopreservation in Breast Cancer Patients. 2016, 39-52. DOI: 10.1007/978-4-431-55963-4_3.Peer-Reviewed Original ResearchBreast cancer patientsCancer patientsFertility preservationEmbryo cryopreservationAdjuvant systemic chemotherapyFertility preservation techniquesOvarian stimulation protocolsBreast cancer casesOvarian stimulationSystemic chemotherapyOvarian reserveIncident casesAromatase inhibitorsBreast cancerCancer casesStimulation protocolPatientsDonor semenCommon typeWomenFuture reproductive potentialCancerPreservation techniquesAttractive strategySpecial consideration
2015
Comparison of random start controlled ovarian stimulation with standard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer
Bedoschi G, Turan V, Emirdar V, Sonmezer M, Oktay K. Comparison of random start controlled ovarian stimulation with standard start in letrozole gonadotropin cycles for fertility preservation in women with breast cancer. Fertility And Sterility 2015, 104: e267. DOI: 10.1016/j.fertnstert.2015.07.838.Peer-Reviewed Original ResearchSafety of controlled ovarian stimulation with gonadotropins and letrozole in women with BRCA mutations
Kim J, Turan V, Oktay K. Safety of controlled ovarian stimulation with gonadotropins and letrozole in women with BRCA mutations. Fertility And Sterility 2015, 104: e265. DOI: 10.1016/j.fertnstert.2015.07.832.Peer-Reviewed Original ResearchLong-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor treatment in women with breast cancer.
Oktay K, Turan V, Kim J. Long-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor treatment in women with breast cancer. Journal Of Clinical Oncology 2015, 33: 9521-9521. DOI: 10.1200/jco.2015.33.15_suppl.9521.Peer-Reviewed Original ResearchOvarian Tissue Cryopreservation: Where Are We Now?
Bedoschi G, Oktay K. Ovarian Tissue Cryopreservation: Where Are We Now? 2015, 71-78. DOI: 10.1007/978-3-319-17849-3_6.Peer-Reviewed Original ResearchFertility preservationOvarian stimulationOvarian cortical piecesAdvanced treatment strategiesPre-pubertal childrenOvarian cryopreservationCortical piecesSurvival outcomesOvarian functionCancer careCancer patientsTreatment strategiesEndocrine functionOocyte cryopreservationAccelerated phaseEarly detectionCancer communityPatientsTransplantationFirst descriptionStimulationSufficient time periodChemotherapySuccessful restorationCancer
2014
Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropin in patients with breast cancer: a prospective controlled study with subgroup analysis
Kim J, Turan V, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropin in patients with breast cancer: a prospective controlled study with subgroup analysis. Fertility And Sterility 2014, 102: e32. DOI: 10.1016/j.fertnstert.2014.07.118.Peer-Reviewed Original ResearchRobotically assisted ovarian tissue transplantation with human extracellular matrix: ovarian stimulation and in vitro fertilization outcomes
Oktay K, Bedoschi G, Pacheco F, Stobezki R, Turan V. Robotically assisted ovarian tissue transplantation with human extracellular matrix: ovarian stimulation and in vitro fertilization outcomes. Fertility And Sterility 2014, 102: e37. DOI: 10.1016/j.fertnstert.2014.07.132.Peer-Reviewed Original Research
2013
Feasibility of ovarian stimulation and oocyte cryopreservation for fertility preservation in female children
Bedoschi G, Turan V, Oktay K. Feasibility of ovarian stimulation and oocyte cryopreservation for fertility preservation in female children. Fertility And Sterility 2013, 100: s63-s64. DOI: 10.1016/j.fertnstert.2013.07.1877.Peer-Reviewed Original Research
2011
OC14.06: The role of antral follicle counts (AFC) via TVUSG in determining fertility preservation outcomes in cancer patients undergoing ovarian stimulation
Arslan E, Karsy M, Moy F, Oktay K. OC14.06: The role of antral follicle counts (AFC) via TVUSG in determining fertility preservation outcomes in cancer patients undergoing ovarian stimulation. Ultrasound In Obstetrics And Gynecology 2011, 38: 27-27. DOI: 10.1002/uog.9171.Peer-Reviewed Original ResearchThe role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation
Arslan E, Karsy M, Moy F, Oktay K. The role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation. Fertility And Sterility 2011, 96: s201. DOI: 10.1016/j.fertnstert.2011.07.778.Peer-Reviewed Original Research
2010
In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation
Oktay K, Buyuk E, Rodriguez-Wallberg K, Sahin G. In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation. Reproductive BioMedicine Online 2010, 20: 634-638. PMID: 20219430, DOI: 10.1016/j.rbmo.2010.01.012.Peer-Reviewed Original ResearchConceptsBreast cancer patientsMature oocyte yieldCancer patientsOvarian stimulationOocyte yieldFertility preservationFertility preservation cyclesMature oocytesCryopreservation cyclesTotal numberSecondary analysisVitro maturationImmature oocytesPatientsIVMEmbryo cryopreservationFertilization rateOocytesStimulationUseful strategyMaturationChemotherapy
2009
Fertility Preservation for Breast Cancer Patients
Oktem O, Oktay K. Fertility Preservation for Breast Cancer Patients. Seminars In Reproductive Medicine 2009, 27: 486-492. PMID: 19806518, DOI: 10.1055/s-0029-1241059.Peer-Reviewed Original ResearchConceptsBreast cancer patientsOvarian stimulation protocolsCancer patientsBreast cancerFertility preservationCancer survivorsStimulation protocolConventional ovarian stimulation protocolsRise of estrogenOvarian tissue freezingBreast cancer survivorsPreservation of fertilityEndogenous estrogen levelsFertility preservation strategiesAromatase inhibitor letrozolePremature ovarian failureNew cancer casesAdjuvant chemotherapyOvarian stimulationFertilization cyclesEstrogen levelsOvarian failureOocyte freezingReproductive ageCommon neoplasm
2007
Safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients undergoing embryo or oocyte cryopreservation: a prospective controlled study
Azim A, Oktay K. Safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients undergoing embryo or oocyte cryopreservation: a prospective controlled study. Fertility And Sterility 2007, 88: s33. DOI: 10.1016/j.fertnstert.2007.07.121.Peer-Reviewed Original Research